June 9, 2026 Experience GSK $10.6 billion acquisition of Nuvalent We are advising GSK on the transaction
June 8, 2026 Experience Inventiva $120 million underwritten offering We advised the underwriters on the offering
May 15, 2026 Experience Oruka Therapeutics collaboration with Halozyme We advised Oruka Therapeutics on the transaction
May 14, 2026 Experience Purdue Pharma completes chapter 11 restructuring We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
May 14, 2026 Experience GH Research $200 million at-the-market offering We advised GH Research on the establishment of the at-the-market program
May 7, 2026 Experience Cross Country Healthcare sale to Knox Lane We are advising Cross Country Healthcare on the transaction
April 20, 2026 Experience McKesson sale of minority stake in Medical-Surgical Solutions to Apollo We are advising McKesson on the transaction